Patient Monitoring Devices Market by Product - Global Industry Analysis and Forecast to 2027

Published On : September 2017 Pages : 95 Category: Medical Devices Report Code : HC06137

SEGMENTS & REGIONS:

  • Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

Industry Trend Analysis

The global patient monitoring market is expected to be around $32 billion by 2027. Some of the major factors driving the market growth are, increasing prevalence of geriatric population around the world, rise in prevalence of different chronic diseases such as diabetes, stroke, cancer and heart diseases and development and innovation in technologically advanced patient monitoring devices. According to the 2017 World Aging Population report by the UN, between 2017 and 2030, the global population aged 60 years and over is expected to grow by XX% from 901 million to 1.4 billion. This number is projected to rise up to 2.1 billion by 2050. With such significant rise in older population worldwide, the demand for advanced patient monitoring devices is set to rapidly increase over the forecast period. However, dearth of skilled and trained professionals to operate sophisticated monitoring devices is expected to hinder the market growth during the forecast period.

Product Outlook and Trend Analysis

In 2017, cardiac monitoring devices segment held a major share of the global patient monitoring devices owing to increasing incidence of cardiovascular disorders around the world. According to the heart disease and stroke statistics published by American Heart Association in 2022, around 92.1 million American adults are suffering from some form of cardiovascular disorder or are affected by the after effects of a stroke. The report further states that in the U.S., heart diseases account for one in every seven deaths. With such high incidence of cardiovascular disorders, the demand for cardiac monitoring devices will favorably increase in coming years thus contributing to the overall market growth.

Regional Outlook and Trend Analysis

North America dominated the global patient monitoring devices market in 2017 by holding a major market share due to factors such as increasing geriatric population, rising incidence of lifestyle diseases and availability of advanced healthcare infrastructure in the region. Asia-Pacific patient monitoring devices market is expected to witness promising growth between 2022 and 2027 owing to the prevalence of unmet medical needs in the region and increasing awareness related to the advantages of patient monitoring devices. With increasing disposable income in countries such as China and India, the demand for patient monitoring devices is expected to significantly increase in coming years in the Asia-Pacific region.

Competitive Analysis

The key players operating in the global patient monitoring devices market focus on product development in order to introduce advanced monitoring products and secure a larger market share. For instance, in September 2017, Nihon Kohden, one of the leading providers of precision medical products and services, launched the advanced bedside monitor called BSM-3500. The monitor is specifically designed to meet the needs of specialty centers and ambulatory surgical centers and offers both premium and standard features. Such innovative product developments will drive this competitive market over the forecast period prompting market players to design and develop advanced monitoring solutions. Some of the major players operating in this market are, Siemens AG, General Electric Company, Nihon Kohden, Omron Healthcare, Inc., Abbott Laboratories Inc., F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., Medtronic plc, BIOTRONIK SE & Co. KG, Masimo Corporation, Johnson & Johnson Services, Inc., LifeWatch AG (acquired by BioTelemetry, Inc.) and Smiths Medical (a part of Smiths Group plc).

Market Opportunities

The key opportunity for the players in the global patient monitoring market lies in product development and strategic acquisitions in order to gain a competitive advantage over other players in the industry and sustain at their position in the market. With acquisitions, companies can strengthen their existing product portfolio and expand their presence in new marketplaces.  

Patient Monitoring Devices Market Segmentation:

By Product:

  • Cardiac Monitoring Devices
  • Event Monitors
  • Electrocardiogram (ECG) Devices
  • Implantable Loop Recorders (ILR)
  • Cardiac Output Monitoring (COM) Devices
  • Respiratory Monitoring Devices
  • Sleep Apnea Monitoring Devices
  • Anesthesia Monitors
  • Capnographs
  • Pulse Oximeters
  • Spirometers
  • Neuromonitoring Devices
  • Intracranial Pressure Monitors (ICP)
  • Cerebral Oximeters
  • Magnetoencephalography (MEG) Devices
  • Electroencephalograph (EEG) Devices
  • Transcranial Dopplers (TCD)
  • Temperature Monitoring Devices
  • Weight Monitoring Devices
  • Multiparameter Monitoring Devices
  • Fetal & Neonatal Monitoring Devices
  • Fetal Doppler
  • Electronic Fetal Monitoring devices (EFM)
  • Ultrasound
  • Remote Patient Monitoring Devices
  • Hemodynamic Monitoring Devices
  • Blood Glucose
  • Blood Gas & Electrolyte Analyzers/Monitors
  • Blood Pressure
  • Cholesterol

By Region:

  • North America
  • U.S
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • Rest of the World
  • Brazil
  • South Africa
  • Saudi Arabia
  • Turkey
  • United Arab Emirates
  • Others

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2022 to 2027?
  • What will be the industry market growth from 2022 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

  • Patient Monitoring Devices Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
    • Cardiac Monitoring Devices
      • Event Monitors
      • Electrocardiogram (ECG) Devices
      • Implantable Loop Recorders (ILR)
      • Cardiac Output Monitoring (COM) Devices
    • Respiratory Monitoring Devices
      • Sleep Apnea Monitoring Devices
      • Anesthesia Monitors
      • Capnographs
      • Pulse Oximeters
      • Spirometers
    • Neuromonitoring Devices
      • Intracranial Pressure Monitors (ICP)
      • Cerebral Oximeters
      • Magnetoencephalography (MEG) Devices
      • Electroencephalograph (EEG) Devices
      • Transcranial Dopplers (TCD)
    • Temperature Monitoring Devices
    • Weight Monitoring Devices
    • Multiparameter Monitoring Devices
    • Fetal & Neonatal Monitoring Devices
      • Fetal Doppler
      • Electronic Fetal Monitoring devices (EFM)
      • Ultrasound
    • Remote Patient Monitoring Devices
    • Hemodynamic Monitoring Devices
      • Blood Glucose
      • Blood Gas & Electrolyte Analyzers/Monitors
      • Blood Pressure
      • Cholesterol
  • Patient Monitoring Devices Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
    • North America
  • North America Patient Monitoring Devices Market, By Country
  • North America Patient Monitoring Devices Market, By Product
    • U.S. Patient Monitoring Devices Market, By Product
    • Canada Patient Monitoring Devices Market, By Product
    • Mexico Patient Monitoring Devices Market, By Product
    • Europe
  • Europe Patient Monitoring Devices Market, By Country
  • Europe Patient Monitoring Devices Market, By Product
    • Germany Patient Monitoring Devices Market, By Product
    • France Patient Monitoring Devices Market, By Product
    • UK Patient Monitoring Devices Market, By Product
    • Italy Patient Monitoring Devices Market, By Product
    • Spain Patient Monitoring Devices Market, By Product
    • Rest of Europe Patient Monitoring Devices Market, By Product
    • Asia-Pacific
      • Asia-Pacific Patient Monitoring Devices Market, By Country
      • Asia-Pacific Patient Monitoring Devices Market, By Product
        • Japan Patient Monitoring Devices Market, By Product
        • China Patient Monitoring Devices Market, By Product
        • Australia Patient Monitoring Devices Market, By Product
        • India Patient Monitoring Devices Market, By Product
        • South Korea Patient Monitoring Devices Market, By Product
        • Rest of Asia-Pacific Patient Monitoring Devices Market, By Product
    • Rest of the World
      • Rest of the World Patient Monitoring Devices Market, By Country
      • Rest of the World Patient Monitoring Devices Market, By Product
        • Brazil Patient Monitoring Devices Market, By Product
        • South Africa Patient Monitoring Devices Market, By Product
        • Saudi Arabia Patient Monitoring Devices Market, By Product
        • Turkey Patient Monitoring Devices Market, By Product
        • United Arab Emirates Patient Monitoring Devices Market, By Product
        • Others Patient Monitoring Devices Market, By Product

Table of Contents

1.Introduction

1.1.Report Description

1.2.Research Methodology

1.2.1. Secondary Research

1.2.2. Primary Research

2.Executive Summary

2.1.Key Highlights

3.Market Overview

3.1.Introduction

3.1.1. Market Definition

3.1.2. Market Segmentation

3.2.Market Share Analysis

3.3.Market Dynamics

3.3.1. Drivers

3.3.1.1.Increasing Geriatric Population Worldwide

3.3.1.2.Technological Advancements in Patient Monitoring Devices

3.3.1.3.Rising Prevalence of Chronic Disorders

3.3.1.4.Increasing Preference towards Home Healthcare by Patient Community

3.3.2. Restraints

3.3.2.1.Dearth of Skilled Professionals to Operate Sophisticated Patient Monitoring Devices

3.3.3. Opportunities

3.3.3.1.Emerging Markets to Offer Lucrative Growth Opportunities

4.Patient Monitoring Devices Market, By Product

4.1.Introduction

4.2.Patient Monitoring Devices Market  Assessment and Forecast, By Product, 2017-2027

4.3.Cardiac Monitoring Devices

4.3.1. Market Assessment and Forecast, By Type, 2017-2027 ($Million)

4.3.2. Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.3.3. Event Monitors

4.3.3.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.3.4. Electrocardiogram (ECG) Devices

4.3.4.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.3.5. Implantable Loop Recorders (ILR)

4.3.5.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.3.6. Cardiac Output Monitoring (COM) Devices

4.3.6.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.4.Respiratory Monitoring Devices

4.4.1. Market Assessment and Forecast, By Type, 2017-2027 ($Million)

4.4.2. Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.4.3. Sleep Apnea Monitoring Devices

4.4.3.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.4.4. Anesthesia Monitors

4.4.4.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.4.5. Capnographs

4.4.5.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.4.6. Pulse Oximeters

4.4.6.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.4.7. Spirometers

4.4.7.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.5.Neuromonitoring Devices

4.5.1. Market Assessment and Forecast, By Type, 2017-2027 ($Million)

4.5.2. Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.5.3. Intracranial Pressure Monitors (ICP)

4.5.3.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.5.4. Cerebral Oximeters

4.5.4.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.5.5. Magnetoencephalograph (MEG) Devices

4.5.5.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.5.6. Electroencephalograph (EEG) Devices

4.5.6.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.5.7. Transcranial Dopplers (TCD)

4.5.7.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.6.Temperature Monitoring Devices

4.6.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.7.Weight Monitoring Devices

4.7.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.8.Multiparameter Monitoring Devices

4.8.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.9.Fetal & Neonatal Monitoring Devices

4.9.1. Market Assessment and Forecast, By Type, 2017-2027 ($Million)

4.9.2. Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.9.3. Fetal Doppler

4.9.3.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.9.4. Electronic Fetal Monitoring devices (EFM)

4.9.4.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.9.5. Ultrasound

4.9.5.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.10.Remote Patient Monitoring Devices

4.10.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.11.Hemodynamic Monitoring Devices

4.11.1.Market Assessment and Forecast, By Type, 2017-2027 ($Million)

4.11.2.Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.11.3.Blood Glucose Monitoring Devices Market

4.11.3.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.11.4.Blood Gas & Electrolyte Analyzers/Monitors

4.11.4.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.11.5.Blood Pressure Monitoring Devices

4.11.5.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)

4.11.6.Cholesterol Monitoring Devices

4.11.6.1.Market Assessment and Forecast, By Region, 2017-2027 ($Million)

5.Patient Monitoring Devices Market, By Region

5.1.Introduction

5.2.Patient Monitoring Devices Market  Assessment and Forecast, By Region, 2017-2027 ($Million)

5.3.North America

5.3.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)

5.3.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

5.3.2.1.U.S.

5.3.2.1.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)

5.3.2.2.Canada

5.3.2.2.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)

5.3.2.3.Mexico

5.3.2.3.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)

5.4.Europe

5.4.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)

5.4.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

5.4.2.1.Germany

5.4.2.1.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)

5.4.2.2.France

5.4.2.2.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)

5.4.2.3.UK

5.4.2.3.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)

5.4.2.4.Italy

5.4.2.4.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)

5.4.2.5.Spain

5.4.2.5.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)

5.4.2.6.Russia

5.4.2.6.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)

5.4.2.7.Rest of Europe

5.4.2.7.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)

5.5.Asia-Pacific

5.5.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)

5.5.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

5.5.2.1.Japan

5.5.2.1.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)

5.5.2.2.China

5.5.2.2.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)

5.5.2.3.Australia

5.5.2.3.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)

5.5.2.4.India

5.5.2.4.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)

5.5.2.5.South Korea

5.5.2.5.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)

5.5.2.6.Taiwan

5.5.2.6.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)

5.5.2.7.Rest of Asia-Pacific

5.5.2.7.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)

5.6.Rest of the World

5.6.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)

5.6.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)

5.6.2.1.Brazil

5.6.2.1.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)

5.6.2.2.Turkey

5.6.2.2.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)

5.6.2.3.Saudi Arabia

5.6.2.3.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)

5.6.2.4.South Africa

5.6.2.4.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)

5.6.2.5.United Arab Emirates

5.6.2.5.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)

5.6.2.6.Others

5.6.2.6.1.Market Assessment and Forecast, By Product, 2017-2027 ($Million)

6.Company Profiles

6.1.Siemens AG

6.1.1. Business Overview

6.1.2. Product Portfolio

6.1.3. Key Financials

6.1.4. Strategic Developments

6.2.General Electric Company

6.2.1. Business Overview

6.2.2. Product Portfolio

6.2.3. Key Financials

6.2.4. Strategic Developments

6.3.Nihon Kohden

6.3.1. Business Overview

6.3.2. Product Portfolio

6.3.3. Key Financials

6.3.4. Strategic Developments

6.4.Omron Healthcare, Inc.

6.4.1. Business Overview

6.4.2. Product Portfolio

6.4.3. Key Financials

6.4.4. Strategic Developments

6.5.Abbott Laboratories Inc.

6.5.1. Business Overview

6.5.2. Product Portfolio

6.5.3. Key Financials

6.5.4. Strategic Developments

6.6.F. Hoffmann-La Roche Ltd

6.6.1. Business Overview

6.6.2. Product Portfolio

6.6.3. Key Financials

6.6.4. Strategic Developments

6.7.Koninklijke Philips N.V.

6.7.1. Business Overview

6.7.2. Product Portfolio

6.7.3. Key Financials

6.7.4. Strategic Developments

6.8.Medtronic plc

6.8.1. Business Overview

6.8.2. Product Portfolio

6.8.3. Key Financinals

6.8.4. Strategic Developments

6.9.Masimo Corporation

6.9.1. Business Overview

6.9.2. Product Portfolio

6.9.3. Kay Financials

6.9.4. Strategic Developments

6.10.Johnson & Johnson Services, Inc.

6.10.1.Business Overview

6.10.2.Product Portfolio

6.10.3.Key Financials

6.10.4.Strategic Developments

6.11.LifeWatch AG

6.11.1.Business Overview

6.11.2.Product Portfolio

6.11.3.Key Financials

6.11.4.Strategic Developments

6.12.Smiths Medical

6.12.1.Business Overview

6.12.2.Product Portfolio

6.12.3.Key Financials

6.12.4.Strategic Developments


List of Tables

Table 1.Global Patient Monitoring Devices Market, By Product ($Million), 2017-2025
Table 2.Cardiac Monitoring Devices Market, By Type ($Million), 2017-2025
Table 3.Cardiac Monitoring Devices Market, By Region ($Million), 2017-2025
Table 4.Event Monitors Market, By Region ($Million), 2017-2025
Table 5.Electrocardiogram (ECG) Devices Market, By Region ($Million), 2017-2025
Table 6.Implantable Loop Recorders (ILR) Market, By Region ($Million), 2017-2025
Table 7.Cardiac Output Monitoring (COM) Devices Market, By Region ($Million), 2017-2025
Table 8.Respiratory Monitoring Devices Market, By Type ($Million), 2017-2025
Table 9.Respiratory Monitoring Devices Market, By Region ($Million), 2017-2025
Table 10.Sleep Apnea Monitoring Devices Market, By Region ($Million), 2017-2025
Table 11.Anesthesia Monitors Market, By Region ($Million), 2017-2025
Table 12.Capnographs Market, By Region ($Million), 2017-2025
Table 13.Pulse Oximeters Market, By Region ($Million), 2017-2025
Table 14.Spirometers Market, By Region ($Million), 2017-2025
Table 15.Neuromonitoring Devices Market, By Type ($Million), 2017-2025
Table 16.Neuromonitoring Devices Market, By Region ($Million), 2017-2025
Table 17.Cerebral Oximeters Market, By Region ($Million), 2017-2025
Table 18.Magnetoencephalograph (MEG) Devices Devices Market, By Region ($Million), 2017-2025
Table 19.Electroencephalograph (EEG) Devices Market, By Region ($Million), 2017-2025
Table 20.Transcranial Dopplers (TCD) Market, By Region ($Million), 2017-2025
Table 21.Temperature Monitoring Devices Market, By Region ($Million), 2017-2025
Table 22.Weight Monitoring Devices Market, By Region ($Million), 2017-2025
Table 23.Multiparameter Monitoring Devices Market, By Region ($Million), 2017-2025
Table 24.Fetal & Neonatal Monitoring Devices Market, By Type ($Million), 2017-2025
Table 25.Fetal & Neonatal Monitoring Devices Market, By Region ($Million), 2017-2025
Table 26.Fetal Doppler Market, By Region ($Million), 2017-2025
Table 27.Electronic Fetal Monitoring devices (EFM) Market, By Region ($Million), 2017-2025
Table 28.Ultrasound Market, By Region ($Million), 2017-2025
Table 29.Remote Patient Monitoring Devices Market, By Region ($Million), 2017-2025
Table 30.Hemodynamic Monitoring Devices Market, By Type ($Million), 2017-2025
Table 31.Hemodynamic Monitoring Devices Market, By Region ($Million), 2017-2025
Table 32.Blood Glucose Monitoring Devices Market, By Region ($Million), 2017-2025
Table 33.Blood Gas & Electrolyte Analyzers/Monitors Market, By Region ($Million), 2017-2025
Table 34.Blood Pressure Monitoring Devices Market, By Region ($Million), 2017-2025
Table 35.Cholesterol Monitoring Devices Market, By Region ($Million), 2017-2025
Table 36.Patient Monitoring Devices Market, By Region ($Million), 2017-2025
Table 37.North America Patient Monitoring Devices Market, By Country, 2017-2025 ($Million)
Table 38.North America Patient Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 39.U.S. Patient Monitoring Devices Market, by Product, 2017-2025 ($Million)
Table 40.Canada Patient Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 41.Mexico Patient Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 42.Europe Patient Monitoring Devices Market, By Country, 2017-2025 ($Million)
Table 43.Europe Patient Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 44.Germany Patient Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 45.France Patient Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 46.UK Patient Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 47.Italy Patient Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 48.Spain Patient Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 49.Russia Patient Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 50.Rest of Europe Patient Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 51.Asia-Pacific Patient Monitoring Devices Market, By Country, 2017-2025 ($Million)
Table 52.Asia-Pacific Patient Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 53.Japan Patient Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 54.China Patient Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 55.Australia Patient Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 56.India Patient Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 57.South Korea Patient Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 58.Taiwan Patient Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 59.Rest of Asia-Pacific Patient Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 60.Rest of the World Patient Monitoring Devices Market, By Country, 2017-2025 ($Million)
Table 61.Rest of the World Patient Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 62.Brazil Patient Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 63.Turkey Patient Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 64.Saudi Arabia Patient Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 65.South Africa Patient Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 66.United Arab Emirates Patient Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 67.Others Patient Monitoring Devices Market, By Product, 2017-2025 ($Million)
Table 68.Siemens AG: Key Strategic Developments, 2017-2017
Table 69.General Electric Company: Key Strategic Developments, 2017-2017
Table 70.Nihon Kohden: Key Strategic Developments, 2017-2017
Table 71.Omron Healthcare, Inc.: Key Strategic Developments, 2017-2017
Table 72.Abbott Laboratories Inc.: Key Strategic Developments, 2017-2017
Table 73.F. Hoffmann-La Roche Ltd: Key Strategic Developments, 2017-2017
Table 74.Koninklijke Philips N.V.: Key Strategic Developments, 2017-2017
Table 75.Medtronic plc: Key Strategic Developments, 2017-2017
Table 76.Masimo Corporation: Key Strategic Developments, 2017-2017
Table 77.Johnson & Johnson Services, Inc.: Key Strategic Developments, 2017-2017
Table 78.LifeWatch AG: Key Strategic Developments, 2017-2017
Table 79.Smiths Medical: Key Strategic Developments, 2017-2017


List of Figures

Figure 1.Global Patient Monitoring Devices Market Share, By Product, 2017 & 2025
Figure 2 Patient Monitoring Devices Market, By Region, 2017, ($Million)
Figure 3.Siemens AG: Net Revenues, 2017-2017 ($Million)
Figure 4.Siemens AG: Net Revenue Share, By Segment, 2017
Figure 5.Siemens AG: Net Revenue Share, By Geography, 2017
Figure 6.General Electric Company: Net Revenues, 2017-2017 ($Million)
Figure 7.General Electric Company: Net Revenue Share, By Segment, 2017
Figure 8.General Electric Company: Net Revenue Share, By Geography, 2017
Figure 9.Nihon Kohden: Net Revenues, 2017-2017 ($Million)
Figure10.Nihon Kohden: Net Revenue Share, By Segment, 2017
Figure 11.Nihon Kohden: Net Revenue Share, By Geography, 2017
Figure 12.Omron Healthcare, Inc.: Net Revenues, 2017-2017 ($Million)
Figure 13.Omron Healthcare, Inc.: Net Revenue Share, By Segment, 2017
Figure 14.Omron Healthcare, Inc.: Net Revenue Share, By Geography, 2017
Figure 15.Abbott Laboratories Inc.: Net Revenues, 2017-2017 ($Million)
Figure 16.Abbott Laboratories Inc.: Net Revenue Share, By Segment, 2017
Figure 17.Abbott Laboratories Inc.: Net Revenue Share, By Geography, 2017
Figure 18.F. Hoffmann-La Roche Ltd: Net Revenues, 2017-2017 ($Million)
Figure 19.F. Hoffmann-La Roche Ltd: Net Revenue Share, By Segment, 2017
Figure 20.F. Hoffmann-La Roche Ltd: Net Revenue Share, By Geography, 2017
Figure 21.Koninklijke Philips N.V.: Net Revenues, 2017-2017 ($Million)
Figure 22.Koninklijke Philips N.V.: Net Revenue Share, By Segment, 2017
Figure 23.Koninklijke Philips N.V.: Net Revenue Share, By Geography, 2017
Figure 24.Medtronic plc: Net Revenues, 2017-2017 ($Million)
Figure 25.Medtronic plc: Net Revenue Share, By Segment, 2017
Figure 26.Medtronic plc: Net Revenue Share, By Geography, 2017
Figure 27.Masimo Corporation: Net Revenues, 2017-2017 ($Million)
Figure 28.Masimo Corporation: Net Revenue Share, By Segment, 2017
Figure 29.Masimo Corporation: Net Revenue Share, By Geography, 2017
Figure 30.Johnson & Johnson Services, Inc.: Net Revenues, 2017-2017 ($Million)
Figure 31.Johnson & Johnson Services, Inc.: Net Revenue Share, By Segment, 2017
Figure 32.Johnson & Johnson Services, Inc.: Net Revenue Share, By Geography, 2017
Figure 33.LifeWatch AG: Net Revenues, 2017-2017 ($Million)
Figure 34.LifeWatch AG: Net Revenue Share, By Segment, 2017
Figure 35.LifeWatch AG: Net Revenue Share, By Geography, 2017
Figure 36.Smiths Medical: Net Revenues, 2017-2017 ($Million)
Figure 37.Smiths Medical: Net Revenue Share, By Segment, 2017
Figure 38.Smiths Medical: Net Revenue Share, By Geography, 2017

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

Related Reports